← Back to Search

Cancer Vaccine

HPV Education for HPV

Phase 4

Recruiting

Led By Gerardo Colon-Otero, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

For female patients, no history of positive HPV testing or abnormal Papanicolaou (Pap) smears

No history of HPV vaccination

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 years

Awards & highlights

Study Summary

This trial looks at whether an educational program about HPV can increase the rates of HPV vaccination among low income uninsured adults, which may prevent HPV-related cancers.

Who is the study for?

This trial is for adults who have never had an HPV vaccine, no allergies to its contents, and women without a history of positive HPV tests or abnormal Pap smears. Participants must understand English, be patients at the VIM clinic, and willing to join the study. Those who've already received the HPV vaccine cannot participate.Check my eligibility

What is being tested?

The trial is testing whether an educational program can increase acceptance and completion of free HPV vaccinations among underserved adults. It aims to boost vaccination rates in this group which may help prevent HPV-related cancers.See study design

What are the potential side effects?

Since this trial involves an educational intervention rather than a medical treatment, there are no direct side effects from medications or vaccines as part of the study itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never had a positive HPV test or abnormal Pap smear.

Select...

I have never received the HPV vaccine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptance and completion rates of free HPV vaccination

Secondary outcome measures

Differences in acceptance and completion rates of HPV vaccination, among patients of different sex, ethnic or race

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prevention (HPV educational program)Experimental Treatment2 Interventions

Patients receive educational materials on HPV and are asked of their willingness to proceed with the first HPV vaccination. Patients who express interest in receiving the HPV vaccination, then receive the first dose of the HPV vaccine and the next 2 doses approximately 2 months and 6 months following the initial vaccine.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,347 Total Patients Enrolled

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,766,783 Total Patients Enrolled

Gerardo Colon-Otero, M.D.Principal InvestigatorMayo Clinic

3 Previous Clinical Trials

486 Total Patients Enrolled

Media Library

HPV Vaccination (Cancer Vaccine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04474821 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I able to join this investigation?

"This trial is recruiting 300 individuals, aged 18 to 45 and infected with human papillomavirus. The essential prerequisites are being a patient of VIM clinic, no history of HPV inoculation or hypersensitivity towards its contents, willingness to engage in the research project and for female participants - negative results on HPV testing and abnormal Papanicolaou (Pap) smears. Additionally, those involved must be able to comprehend English."

Answered by AI

Is the enrollment of geriatric participants part of this investigation?

"According to the inclusion criteria, this trial is open for applicants between 18 and 45 years old. Alternatively, there are 20 studies available for minors under 18 and 36 trials that accommodate seniors over 65."

Answered by AI

Is this investigation actively enrolling participants?

"Affirmative. Information hosted on clinicaltrials.gov affirms that this medical trial is presently seeking volunteers, having first been published on October 19th 2020 and edited as recently as May 17th 2022. The project requires 300 test subjects from a single location."

Answered by AI

How many participants are being invited to participate in this experiment?

"Affirmative, the information on clinicaltrials.gov reveals that this trial is actively recruiting participants. The listing appeared online October 19th 2020 and was last revised May 17th 2022. This research endeavour requires 300 volunteers from a single medical centre to complete it successfully."

Answered by AI

To what extent can Educational Intervention be hazardous to those receiving it?

"The safety of the educational intervention was marked a 3 on our scale due to its approval in Phase 4 trials, which speaks volumes about its efficacy."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

2020. "HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04474821.

All > Hpv